Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine

TUESDAY, July 28, 2026-- For adults with muscle-invasive bladder cancer, the combination of enfortumab vedotin and pembrolizumab is associated with improved event-free and overall survival compared with cisplatin and gemcitabine, according to a...